Research Report on China Swine Fever Vaccine Industry, 2013-2017

30 pages report Published in
Pharmaceuticals
Publisher: China Research and Intelligence

arrowFor This Report

Swine fever is an acute, hyperpyretic and contagious disease, caused by swine fever viruses. Its incidence rate and death rate are both extremely high, and viruses can be transmitted at high speed. Immunization is the major measure to prevent swine fever.

With the development of Chinese economy and increasing living standards of Chinese people, the demand for pork keeps growing accordingly. In 2012, the output volume of pork in China was 53.35 million tons, increasing by 5.6% YOY. The fattened volume of pigs in 2012 was 696.28 million, increasing by 5.2% YOY. With the expansion of the pig raising industry, farmers in China have an increasing demand for swine fever vaccines.

In 2007, Chinese government started to conduct compulsory immunizations against swine fever, According to National Compulsory Immunization Plan of Animal Epidemic Diseases 2013 issued by Ministry of Agriculture and Ministry of Finance, 4 diseases are covered by the national compulsory immunization program, including swine fever. The appropriation of animal epidemic prevention in China is proportionally sponsored by both central and local governments. The proportion is determined based on relevant documents jointly issued by Ministry of Agriculture and Ministry of Finance. However, the swine fever vaccines procured by the government were low-priced and their qualities are not guaranteed. At present, there are many enterprises that produce swine fever vaccines in China, but the qualities of their vaccines vary. Some animal healthcare experts advocate the cancellation of government procurement of swine fever vaccines. Instead, the government can directly provide subsidies to farmers.

If each pig must be vaccinated for twice, the market scale of China swine fever vaccines in 2012 was about 1.4 billion doses. Assuming that the number of pigs raised increases by 5%-10% every year, the annual demand volume of swine fever vaccines will also increase under normal conditions. For those animal vaccine producing and trading enterprises, there are many opportunities in China market.

Through this report, the readers can acquire the following information:

  • Incidence status and prevention program of swine fever in China
  • Overview of China pig raising industry
  • Supply and demand status of China swine fever vaccines
  • Factors influencing the development of swine fever vaccine market
  • Government procurement system of swine fever vaccines
  • Perspective of swine fever vaccine industry

The following enterprises and people are proposed to purchase this report:

  • Animal vaccine producing enterprises
  • Pig raising enterprises
  • Government departments
  • -Investors/research institutes concerned about animal vaccines

Table of Contents


1 Relevant Concepts of Swine Fever Vaccines

1.1 Definition and Incidence Status of Swine Fever

1.1.1 Definition

1.1.2 Global Incidence Status of Swine Fever

1.1.3 Prevention and Controlling Measures of Swine Fever

1.2 Classification of Swine Fever Vaccines


2 Development Environment of China Swine Fever Vaccine Industry, 2012-2013

2.1 Policies of Animal Vaccine Industry

2.1.1 Legislation of Animal Epidemic Prevention

2.1.2 Organization Structure

2.1.3 Appropriation Budget of Chinese Government for Epidemic Prevention

2.1.4 Scope of Compulsory Immunization Program

2.2 Status of Pig Raising Industry, 2008-2012

2.2.1 Pig Raising Status

2.2.2 Development Characteristics of China Pig Raising Industry, 2012-2013

2.3 Incidence Status of Swine Fever in China, 2012-2013

2.3.1 Overview

2.3.2 Major Incidences of Swine Fever


3 Performance of China Swine Fever Vaccine Industry, 2008-2012

3.1 Supply Status

3.1.1 Major Enterprises

3.1.2 Factors Influencing Supply

3.1.3 Analysis of Output Volume

3.2 Demand

3.2.1 Demand Status

3.2.2 Factors Influencing Demand

3.3 Processes and Problems of Immunization Against Swine Fever

3.3.1 Use of Swine Fever Vaccines

3.3.2 Problems of Government Procurement of Swine Fever Vaccines

3.3.3 Lot Release System of Swine Fever Vaccines


4 Major Swine Fever Vaccine Producing Enterprises in China, 2012-2013

4.1 Ringpu Bio-Pharmacy Co., Ltd.

4.1.1 Enterprise Profile

4.1.2 Production Status of Swine Fever Vaccines

4.1.3 Enterprise Development Strategies

4.2 Sichuan Huapai Bio-pharmaceutical Co., Ltd.

4.3 Pu-Like Bio-Enginerring Co., Ltd.

4.4 Harbin Pharmaceutical Group Biological Vaccines Co., Ltd.

4.5 Chengdu TECBOND Biological Products CO., Ltd


5 Tendering Procurement Results of Swine Fever Vaccines in Some Regions of China, 2012-2013

5.1 Sichuan

5.2 Shaanxi

5.3 Jilin


6 Prospective of China Swine Fever Vaccine Industry, 2013-2017

6.1 Analysis of Factors Influencing Development

6.1.1 Government Policy Trends

6.1.2 Forecast on Pig Raising Industry

6.2 Forecast on Supply and Demand

6.2.1 Forecast on Supply of Swine Fever Vaccines

6.2.2 Forecast on Demand of Swine Fever Vaccines

6.3 Investment and Development Recommendations for Swine Fever Vaccine Industry


List of Charts


Chart Epidemic Prevention Appropriation of Chinese Government, 2009-2012

Chart Major Incidences of Swine Fever in China, 2012-2013

Chart Output Volume of China Swine Fever Vaccines, 2008-2012

Chart Scale of China Swine Fever Vaccine Market, 2008-2012

Chart Tendering Procurement Result Publicity of Swine Fever Vaccines in Sichuan, 2013

Chart Forecast on China Pig Fattened Volume, 2013-2017

Chart Forecast on Scale of China Swine Fever Vaccine Market, 2013-2017


Related Reports

  • Research Report on China Swine Fever Vaccine Industry, 2014-2018China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one […]
  • Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry, 2014-2018China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of hogs was 474.11 million, down by 0.4% compared to 2012. The stock volume of fattened hogs was […]
  • Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate […]
  • Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2013-2017In China, PRRS is the most serious disease that impairs the pig raising & breeding industry. It inflicted heavy losses on China pig raising & breeding industry for many times. In April 2007, Ministry of Agriculture of China issued Technical Standards of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Prevention and Treatment, and classified HP-PRRS into serious animal epidemic diseases which are covered by the national compulsory immunization program. Based […]
  • Research on China Animal Vaccine Industry, 2015From 2001, FMD, HPAI, PRRS and Swine were respectively been included in compulsory immunity vaccines, meanwhile, China’s animal vaccine industry experienced a rapid development with a CAGR of 19.2 from 2000 to 2014. Currently the market size of China’s animal vaccine industry has exceeded RMB 9 billion, which mainly formed up by pig and poultry vaccines with a respectively market share of 49% and 40% in 2014. FMD Vaccine: Currently there are only 7 enterprises received the […]